At the Seraph Research Institute (SRI) in Los Angeles,scientists presentednew research at the 2021 Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT) that shows promise in treating HIV. The study was presented by Serhat Gumrukcu, director of SRI and his team
DUBLIN, May 14, 2021 /PRNewswire/ -- The "Global Stem Cell Therapy Market by Type (Allogeneic, Autologous), Therapeutic Application (Musculoskeletal, Wound & Injury, CVD, Autoimmune & Inflammatory), Cell Source (Adipose tissue, Bone Marrow, Placenta/Umbilical Cord) - Forecasts to 2026" report has been added to ResearchAndMarkets.com's offering. The global stem cell therapy market is projected to reach USD 401 million by 2026 from USD 187 million in 2021, at a CAGR of 16.5% during the forecast period. Growth in this market is majorly driven by the increasing investment in stem cell research and the rising number of GMP-certified stem cell manufacturing plants.However, factors such as ethical concerns and the high cost of stem cell research and manufacturing process likely to hinder the growth of this market
MarketQuest.biz presents the top quality and comprehensive research on Global Stem Cell Reconstructive Market 2021 by Company, Regions, Type and Application, Forecast to 2026 which offers a detailed survey of the market in communicative format, covering the past data and calculating 2021-2026. The report throws light on some of the leading factors related to the global Stem Cell Reconstructive market.
Watch here: https://www.youtube.com/channel/UCFi6QNwlsa453cKBy5faAYw press release: Heart disease, also known as cardiovascular disease, is the leading cause of death in the United States.
SHEFFIELD, England, May 13, 2021 /PRNewswire/ -- Rinri Therapeutics ('Rinri'), a biotechnology company developing a novel cell-based therapy to restore hearing loss, is delighted to announce that it has secured, a grant from Innovate UK, the UK's innovation agency.
CAMBRIDGE, Mass. and AVENTURA, Fla., May 13, 2021 (GLOBE NEWSWIRE) -- Cytovia Therapeutics, Inc., a biopharmaceutical company developing allogeneic off-the-shelf gene-edited Chimeric Antigen Receptor (CAR)-NK cells derived from induced pluripotent stem cells (iPSCs) and NK cell engager multifunctional antibodies, announced today that Jason Aryeh, a long time biotech investor and board director, has been elected to the Cytovia Board of Directors, effective immediately
Stem Cell and Regenerative Therapy Market research report provides the details about Industry Chain structure, Market Competition, Market Size & Share, SWOT Analysis, Technology, Cost, Raw Materials, Consumer Preference, Development & Trends, Regional Forecast, Company & Profile, and Product & Service.
CRANBURY, N.J.--(BUSINESS WIRE)-- Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a clinical-stage company advancing an integrated and sustainable pipeline of genetic therapies for rare childhood disorders, today announces positive clinical data from its Fanconi Anemia (FA), Leukocyte Adhesion Deficiency-I (LAD-I), and Pyruvate Kinase Deficiency (PKD) gene therapy programs presented at the 24th American Society of Gene and Cell Therapy (ASGCT) Annual Meeting
Coral reefs face myriad stressors, from pollution to climate change. Understanding how they respond to these threats on a molecular level is essential for predicting what will happen to them in the years to come and devising the best means of protecting them, says Tali Mass, a marine ecologist at the University of Haifa in Israel. Unfortunately, relatively scant knowledge about the different cell types in their bodies has hindered that kind of research
You are here: 12 May 2021 PhD student Meg McFetridge has received a coveted Fulbright Future Scholarship Meg McFetridge was first inspired by mechanobiology in her honours year, watching stem cells on hydrogel surfaces. One end of the hydrogel was soft, the other end stiff, with a stiffness gradient in between
Recent Comments